Official Publications PHAXIAM Therapeutics S.A.

Equities

End-of-day quote Euronext Paris Other stock markets 06:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
3.025 ^EUR	+0.83%		+4.31%	-34.24%

Apr. 15	Phaxiam initiates trial in infective endocarditis	CF
Apr. 15	PHAXIAM Therapeutics Announces Enrolment of First Patient in the Phase 1 Study for the Treatment of Endocarditis Infections Caused by Staphylococcus Aureus	CI

Monthly statement on voting rights	Apr. 29	CO
Monthly statement on voting rights	Apr. 29	CO
Universal registration document	Apr. 04	CO
Monthly statement on voting rights	Mar. 30	CO
Monthly statement on voting rights	Mar. 30	CO
Annual results	Mar. 19	CO
Annual results	Mar. 19	CO
Monthly statement on voting rights	Feb. 28	CO
Monthly statement on voting rights	Feb. 28	CO
Monthly statement on voting rights	Jan. 30	CO
Monthly statement on voting rights	Jan. 30	CO
Provisional calendar	Jan. 17	CO
Provisional calendar	Jan. 17	CO
Monthly statement on voting rights	Dec. 30	CO
Monthly statement on voting rights	Dec. 30	CO
Monthly statement on voting rights	Nov. 29	CO
Monthly statement on voting rights	Nov. 29	CO
Monthly statement on voting rights	23-10-30	CO
Monthly statement on voting rights	23-10-30	CO
Various reports	23-09-28	CO
Half-year report	23-09-25	CO
1st-half-year results	23-09-20	CO
1st-half-year results	23-09-20	CO
Monthly statement on voting rights	23-08-30	CO
Monthly statement on voting rights	23-08-30	CO